Note 5. Fair Value Disclosures | | | | | |
| |
| | | | Counterparty and Cash Collateral Netting (2) | |
| | | | | |
Financial instruments owned: | | | | | |
Corporate equity securities .................................................................................. | | | | | |
Corporate debt securities ..................................................................................... | | | | | |
Collateralized debt obligations and collateralized loan obligations ............... | | | | | |
U.S. government and federal agency securities ................................................ | | | | | |
Municipal securities .............................................................................................. | | | | | |
Sovereign obligations ............................................................................................ | | | | | |
Residential mortgage-backed securities ............................................................ | | | | | |
Commercial mortgage-backed securities .......................................................... | | | | | |
Other asset-backed securities ............................................................................. | | | | | |
Loans and other receivables ................................................................................ | | | | | |
Derivatives .............................................................................................................. | | | | | |
Investments at fair value ...................................................................................... | | | | | |
Total financial instruments owned, excluding Investments at fair value based on NAV .................................................................................................... | | | | | |
Securities received as collateral .......................................................................... | | | | | |
| | | | | |
| | | | | |
Financial instruments sold, not yet purchased: | | | | | |
Corporate equity securities .................................................................................. | | | | | |
Corporate debt securities ..................................................................................... | | | | | |
Collateralized debt obligations and collateralized loan obligations ............... | | | | | |
U.S. government and federal agency securities ................................................ | | | | | |
Sovereign obligations ............................................................................................ | | | | | |
Loans ....................................................................................................................... | | | | | |
Derivatives .............................................................................................................. | | | | | |
Total financial instruments sold, not yet purchased ....................................... | | | | | |
Other secured financings ...................................................................................... | | | | | |
Obligation to return securities received as collateral ....................................... | | | | | |
Long-term debt ....................................................................................................... | | | | | |
(1)Excludes investments at fair value based on net asset value (“NAV”) of $1.68 billion at November 30, 2025 by level within the fair value hierarchy.
(2)Represents counterparty and cash collateral netting across the levels of the fair value hierarchy for positions with the same counterparty.
| | | | | |
| |
| | | | Counterparty and Cash Collateral Netting (2) | |
| | | | | |
Financial instruments owned: | | | | | |
Corporate equity securities .................................................................................. | | | | | |
Corporate debt securities ..................................................................................... | | | | | |
Collateralized debt obligations and collateralized loan obligations ............... | | | | | |
U.S. government and federal agency securities ................................................ | | | | | |
Municipal securities .............................................................................................. | | | | | |
Sovereign obligations ............................................................................................ | | | | | |
Residential mortgage-backed securities ............................................................ | | | | | |
Commercial mortgage-backed securities .......................................................... | | | | | |
Other asset-backed securities ............................................................................. | | | | | |
Loans and other receivables ................................................................................ | | | | | |
Derivatives .............................................................................................................. | | | | | |
Investments at fair value ...................................................................................... | | | | | |
Total financial instruments owned, excluding Investments at fair value based on NAV .................................................................................................... | | | | | |
Securities segregated and on deposit for regulatory purposes or deposited with clearing and depository organizations ................................ | | | | | |
Securities received as collateral .......................................................................... | | | | | |
| | | | | |
| | | | | |
Financial instruments sold, not yet purchased: | | | | | |
Corporate equity securities .................................................................................. | | | | | |
Corporate debt securities ..................................................................................... | | | | | |
U.S. government and federal agency securities ................................................ | | | | | |
Sovereign obligations ............................................................................................ | | | | | |
Commercial mortgage-backed securities ......................................................... | | | | | |
Loans ....................................................................................................................... | | | | | |
Derivatives .............................................................................................................. | | | | | |
Total financial instruments sold, not yet purchased ....................................... | | | | | |
Other secured financings ...................................................................................... | | | | | |
Obligation to return securities received as collateral ...................................... | | | | | |
Long-term debt ....................................................................................................... | | | | | |
(1)Excludes investments at fair value based on NAV of $1.25 billion at November 30, 2024 by level within the fair value hierarchy.
(2)Represents counterparty and cash collateral netting across the levels of the fair value hierarchy for positions with the same counterparty.
The following is a description of the valuation basis, including valuation techniques and inputs, used in measuring our financial
assets and liabilities that are accounted for at fair value on a
recurring basis:
Cash and securities segregated and on deposit for regulatory
purposes or deposited with clearing and depository organizations
Segregated U.S. Treasury securities are measured based on
quoted market prices obtained from external pricing services and
categorized within Level 1 of the fair value hierarchy.
Corporate Equity Securities
•Exchange-Traded Equity Securities: Exchange-traded equity
securities are measured based on quoted closing exchange
prices, which are generally obtained from external pricing
services, and are categorized within Level 1 of the fair value
hierarchy. Otherwise, they are categorized within Level 2 of the
fair value hierarchy to the extent these securities are actively
traded and valuation adjustments are not applied..
•Non-Exchange-Traded Equity Securities: Non-exchange-traded
equity securities are measured, where available, using broker
quotations, pricing data from external pricing services and
prices observed from recently executed market transactions
and are categorized within Level 2 of the fair value hierarchy.
Where such information is not available, non-exchange-traded
equity securities are categorized within Level 3 of the fair value
hierarchy and measured using valuation techniques involving
quoted prices of or market data for comparable companies,
similar company ratios and multiples (e.g., price/Earnings
before interest, taxes, depreciation and amortization
(“EBITDA”), price/book value), discounted cash flow analyses
and transaction prices observed from subsequent financing or
capital issuance by the company. When using pricing data of
comparable companies, judgment must be applied to adjust
the pricing data to account for differences between the
measured security and the comparable security (e.g., issuer
market capitalization, yield, dividend rate, geographical
concentration).
•Equity Warrants: Non-exchange-traded equity warrants are
measured primarily from observed prices on recently executed
market transactions and broker quotations and are categorized
within Level 2 of the fair value hierarchy. Where such
information is not available, non-exchange-traded equity
warrants are generally categorized within Level 3 of the fair
value hierarchy and can be measured using third-party
valuation services or the Black-Scholes model with key inputs
impacting the valuation including the underlying security price,
implied volatility, dividend yield, interest rate curve, strike price
and maturity date.
Corporate Debt Securities
•Investment Grade Corporate Bonds: Investment grade
corporate bonds are measured primarily using pricing data
from external pricing services and broker quotations, where
available, prices observed from recently executed market
transactions and bond spreads. Investment grade corporate
bonds measured using these valuation methods are
categorized within Level 2 of the fair value hierarchy. If broker
quotes, pricing data or spread data is not available, alternative
valuation techniques may be used. Investment grade corporate
bonds measured using alternative valuation techniques are
categorized within Level 2 or Level 3 of the fair value hierarchy.
•High Yield Corporate and Convertible Bonds: A significant
portion of our high yield corporate and convertible bonds are
categorized within Level 2 of the fair value hierarchy and are
measured primarily using pricing data from external pricing
services and broker quotations, where available, and prices
observed from recently executed market transactions of
institutional size. Where pricing data is less observable,
valuations are categorized within Level 3 of the fair value
hierarchy and are based on pending transactions involving the
issuer or comparable issuers, prices implied from an issuer’s
subsequent financing or recapitalization, models incorporating
financial ratios and projected cash flows of the issuer and
market prices for comparable issuers.
Collateralized Debt Obligations and Collateralized Loan
Obligations
Collateralized debt obligations (“CDOs”) and collateralized loan
obligations (“CLOs”) are measured based on prices observed
from recently executed market transactions of the same or
similar security or based on valuations received from third-party
brokers or data providers and are categorized within Level 2 or
Level 3 of the fair value hierarchy depending on the observability
and significance of the pricing inputs. Valuation that is based on
recently executed market transactions of similar securities
incorporates additional review and analysis of pricing inputs and
comparability criteria, including, but not limited to, collateral type,
tranche type, rating, origination year, prepayment rates, default
rates and loss severity.
U.S. Government and Federal Agency Securities
•U.S. Treasury Securities: U.S. Treasury securities are measured
based on quoted market prices obtained from external pricing
services and categorized within Level 1 of the fair value
hierarchy.
•U.S. Agency Debt Securities: Callable and non-callable U.S.
agency debt securities are measured primarily based on
quoted market prices obtained from external pricing services
and are generally categorized within Level 1 or Level 2 of the
fair value hierarchy.
Municipal Securities
Municipal securities are measured based on quoted prices
obtained from external pricing services, where available, or
recently executed independent transactions of comparable size
and are generally categorized within Level 2 of the fair value
hierarchy.
Sovereign Obligations
Sovereign government obligations are measured based on
quoted market prices obtained from external pricing services,
where available, or recently executed independent transactions of
comparable size. Sovereign government obligations, with
consideration given to the country of issuance, are generally
categorized within Level 1 or Level 2 of the fair value hierarchy.
Residential Mortgage-Backed Securities
•Agency Residential Mortgage-Backed Securities (“RMBS”):
Agency RMBS include mortgage pass-through securities (fixed
and adjustable rate), collateralized mortgage obligations and
principal-only and interest-only (including inverse interest-only)
securities. Agency RMBS are generally measured using recent
transactions, pricing data from external pricing services or
expected future cash flow techniques that incorporate
prepayment models and other prepayment assumptions to
amortize the underlying mortgage loan collateral and are
categorized within Level 2 or Level 3 of the fair value hierarchy.
We use prices observed from recently executed transactions to
develop market-clearing spread and yield assumptions.
Valuation inputs with regard to the underlying collateral
incorporate factors such as weighted average coupon, loan-to-
value, credit scores, geographic location, maximum and
average loan size, originator, servicer and weighted average
loan age.
•Non-Agency RMBS: The fair value of non-agency RMBS is
determined primarily using pricing data from external pricing
services, where available, and discounted cash flow
methodologies and securities are categorized within Level 2 or
Level 3 of the fair value hierarchy based on the observability
and significance of the pricing inputs used. Performance
attributes of the underlying mortgage loans are evaluated to
estimate pricing inputs, such as prepayment rates, default
rates and the severity of credit losses. Attributes of the
underlying mortgage loans that affect the pricing inputs
include, but are not limited to, weighted average coupon;
average and maximum loan size; loan-to-value; credit scores;
documentation type; geographic location; weighted average
loan age; originator; servicer; historical prepayment, default
and loss severity experience of the mortgage loan pool; and
delinquency rate. Yield curves used in the discounted cash flow
models are based on observed market prices for comparable
securities and published interest rate data to estimate market
yields. In addition, broker quotes, where available, are also
referenced to compare prices.
Commercial Mortgage-Backed Securities
•Agency Commercial Mortgage-Backed Securities (“CMBS”):
Government National Mortgage Association (“Ginnie Mae”)
project loan bonds are measured using recent transactions,
pricing data from external pricing services or discount cash
flow methodologies with inputs corroborated from and
benchmarked to observed prices of recent securitization
transactions of similar securities with adjustments
incorporating an evaluation of various factors, including
prepayment speeds, default rates and cash flow structures.
Federal National Mortgage Association (“Fannie Mae”)
Delegated Underwriting and Servicing (“DUS”) mortgage-
backed securities are generally measured by using prices
observed from recently executed market transactions to
estimate market-clearing spread levels for purposes of
estimating fair value. Ginnie Mae project loan bonds and
Fannie Mae DUS mortgage-backed securities are categorized
within Level 2 of the fair value hierarchy.
•Non-Agency CMBS: Non-agency CMBS are measured using
pricing data obtained from external pricing services, prices
observed from recently executed market transactions or based
on expected cash flow models that incorporate underlying loan
collateral characteristics and performance. Non-Agency CMBS
are categorized within Level 2 or Level 3 of the fair value
hierarchy depending on the observability of the underlying
inputs.
Other Asset-Backed Securities
Other asset-backed securities (“ABS”) include, but are not limited
to, securities backed by auto loans, credit card receivables,
student loans and other consumer loans and are categorized
within Level 2 or Level 3 of the fair value hierarchy. Valuations are
primarily determined using pricing data obtained from external
pricing services, broker quotes and prices observed from recently
executed market transactions. In addition, recent transaction
data from comparable deals is deployed to develop market
clearing yields and cumulative loss assumptions. The cumulative
loss assumptions are based on the analysis of the underlying
collateral and comparisons to earlier deals with similar collateral
to gauge the relative performance of the deal.
Loans and Other Receivables
•Corporate Loans: Corporate loans categorized within Level 2 of
the fair value hierarchy are measured based on market
consensus pricing service quotations. Where available, market
price quotations from external pricing services are reviewed to
ensure they are supported by transaction data. Corporate loans
categorized within Level 3 of the fair value hierarchy are
measured based on price quotations that are considered to be
less observable. Price quotations are derived using market
prices for debt securities of the same creditor and estimates of
future cash flows. Future cash flows use assumptions
regarding creditor default and recovery rates, credit rating,
effective yield and consideration of the issuer’s capital
structure.
•Participation Certificates in Agency Residential Loans:
Valuations of participation certificates in agency residential
loans are based on observed market prices of recently
executed purchases and sales of similar loans and data
provider pricing. The loan participation certificates are
categorized within Level 2 of the fair value hierarchy given the
observability and volume of recently executed transactions and
availability of data provider pricing.
•Project Loans and Participation Certificates in Ginnie Mae
Project and Construction Loans: Valuations of participation
certificates in Ginnie Mae project and construction loans are
based on inputs corroborated from and benchmarked to
observed prices of recent securitizations with similar
underlying loan collateral to derive an implied spread.
Securitization prices are adjusted to estimate the fair value of
the loans to account for the arbitrage that is realized at the
time of securitization. The measurements are categorized
within Level 2 of the fair value hierarchy given the observability
and volume of recently executed transactions.
•Consumer Loans and Funding Facilities: Consumer and small
business whole loans and related funding facilities are valued
based on observed market transactions and incorporating
valuation inputs including, but not limited to, delinquency and
default rates, prepayment rates, borrower characteristics, loan
risk grades and loan age. These assets are categorized within
Level 2 or Level 3 of the fair value hierarchy.
•Escrow and Claim Receivables: Escrow and claim receivables
are categorized within Level 2 of the fair value hierarchy where
fair value is based on recent observations in the same
receivable. Escrow and claim receivables are categorized
within Level 3 of the fair value hierarchy where fair value is
estimated based on reference to market prices and implied
yields of debt securities of the same or similar issuers.
Derivatives
•Listed Derivative Contracts: Listed derivative contracts that are
actively traded are measured based on quoted exchange
prices, broker quotes or vanilla option valuation models, such
as Black-Scholes, using observable valuation inputs from the
principal market or consensus pricing services. Exchange
quotes and/or valuation inputs are generally obtained from
external vendors and pricing services. Broker quotes are
validated that they are tradeable. Listed derivative contracts
that use exchange close prices are generally categorized within
Level 1 of the fair value hierarchy. All other listed derivative
contracts are generally categorized within Level 2 of the fair
value hierarchy.
•Over-the-Counter (“OTC”) Derivative Contracts: OTC derivative
contracts are generally valued using models, whose inputs
reflect assumptions that we believe market participants would
use in valuing the derivative in a current transaction. Where
available, valuation inputs are calibrated from observable
market data. For many OTC derivative contracts, the valuation
models do not involve material subjectivity as the
methodologies do not entail significant judgment and the
inputs to valuation models do not involve a high degree of
subjectivity as the valuation model inputs are readily
observable or can be derived from actively quoted markets.
OTC derivative contracts are primarily categorized within Level
2 of the fair value hierarchy given the observability and
significance of the inputs to the valuation models. Where
significant inputs to the valuation are unobservable, derivative
instruments are categorized within Level 3 of the fair value
hierarchy.
OTC options include OTC equity, foreign exchange, interest rate
and commodity options measured using various valuation
models, such as Black-Scholes, with key inputs including the
underlying security price, foreign exchange spot rate,
commodity price, implied volatility, dividend yield, interest rate
curve, strike price and maturity date. Discounted cash flow
models are utilized to measure certain OTC derivative
contracts including the valuations of our interest rate swaps,
which incorporate observable inputs related to interest rate
curves, valuations of our foreign exchange forwards and
swaps, which incorporate observable inputs related to foreign
currency spot rates and forward curves and valuations of our
commodity swaps and forwards, which incorporate observable
inputs related to commodity spot prices and forward curves.
Credit default swaps include both index and single-name credit
default swaps. Where available, external data is used in
measuring index credit default swaps and single-name credit
default swaps. For commodity and equity total return swaps,
market prices are generally observable for the underlying asset
and used as the basis for measuring the fair value of the
derivative contracts. Total return swaps executed on other
underlyings are measured based on valuations received from
external pricing services.
Securities Received as Collateral / Obligations to Return Securities
Received as Collateral
In connection with securities-for-securities transactions in which
we are the lender of securities and are permitted to sell or
repledge the securities received as collateral, we report the fair
value of the collateral received and the related obligation to
return the collateral. Valuation is based on the price of the
underlying security and is categorized within the corresponding
leveling guidance above. These financial instruments are typically
categorized within Level 1 of the fair value hierarchy.
Other Secured Financings
Other secured financings that are accounted for at fair value are
classified within Level 2 or Level 3 of the fair value hierarchy. Fair
value is based on estimates of future cash flows incorporating
assumptions regarding recovery rates.
Long-term Debt
Long-term debt includes structured notes where valuation is
linked to the performance of a specific index, a specific equity
security or various interest rate-related features, such as
embedded options (caps, floors, and collars), callable or puttable
provisions, step-up or step-down coupon structures, and floating-
rate components tied to benchmark indices (e.g., SOFR,
EURIBOR). The various valuation models incorporate our own
credit spread, market price quotations from external pricing
sources referencing the appropriate interest rate curves,
volatilities and other inputs as well as prices for transactions in a
given note during the period. Long-term debt notes are generally
categorized within Level 2 of the fair value hierarchy where
market trades have been observed during the period, otherwise
the notes are categorized within Level 3.
Investments at Fair Value Investments at fair value includes investments in hedge funds,
private equity funds, credit funds, real estate funds and other
funds, which are measured at the NAV of the funds, provided by
the fund managers and are excluded from the fair value
hierarchy. Investments at fair value also include direct equity
investments in private companies, which are measured at fair
value using valuation techniques involving quoted prices of or
market data for comparable companies, similar company ratios
and multiples (e.g., price/EBITDA, price/book value), discounted
cash flow analyses and transaction prices observed for
subsequent financing or capital issuance by the company. Direct
equity investments in private companies are categorized within
Level 2 or Level 3 of the fair value hierarchy.
Information about our investments in entities that have the
characteristics of an investment company:
| | | | |
| |
| | | | |
Hedge Funds (2) .............. | | | Quarterly (42%) Monthly (41%) N/R (17%) | 45 - 90 days 45 - 60 days N/R |
Private Equity Funds (3) .............. | | | | |
Credit Funds (4) .............. | | | Quarterly (56%) Monthly (2%) N/R (42%) | |
Real Estate and Other Funds (5) .... | | | | |
Total ...................... | | | | |
| | | | |
| |
| | | | |
Hedge Funds (2) ............ | | | Quarterly (53%) Monthly (47%) | |
Private Equity Funds (3) ............ | | | | |
| | | Quarterly (72%) Monthly (3%) N/R (25%) | |
Real Estate and Other Funds (5) . | | | | |
Total ................... | | | | |
N/R - Not redeemable
(1)Where fair value is calculated based on NAV, fair value has been derived from
each of the funds’ capital statements.
(2)Includes investments in hedge funds that invest, long and short, primarily in
both public and private equity securities in domestic and international
markets, commodities and multi-asset securities.
(3)Includes investments in equity funds that invest in the equity of various U.S.
and foreign private companies in a broad range of industries. These
investments cannot be redeemed; instead, distributions are received through
the liquidation of the underlying assets of the funds which are primarily
expected to be liquidated in approximately one to nine years.
(4)Primarily includes investments in funds that invest in:
•Distressed and special situations long/short credit strategies across
sectors and asset types;
•Short-term trade receivables and payables that are expected to generally be
outstanding between 90 to 120 days; and
•Distressed and event-driven opportunities across structured credit,
opportunistic credit, and private credit.
(5)Primarily includes investments in corporate real estate strategies focused on
buying or building real estate businesses.
Level 3 Rollforwards | | | | | | | | | | |
| | | | | | | | | For instruments still held at November 30, 2025, changes in unrealized gains/(losses) included in: |
| Balance at November 30, 2024 | Total gains/ losses (realized and unrealized) (1) | | | | | Net transfers into/ (out of) Level 3 | Balance at November 30, 2025 | | Other comprehensive income (1) |
| | | | | | | | | | |
Financial instruments owned: | | | | | | | | | | |
Corporate equity securities ... | | | | | | | | | | |
Corporate debt securities ...... | | | | | | | | | | |
CDOs and CLOs ....................... | | | | | | | | | | |
Sovereign obligations ............. | | | | | | | | | | |
RMBS ........................................ | | | | | | | | | | |
CMBS ........................................ | | | | | | | | | | |
Other ABS ................................. | | | | | | | | | | |
Loans and other receivables . | | | | | | | | | | |
Investments at fair value ....... | | | | | | | | | | |
| | | | | | | | | | |
Financial instruments sold, not yet purchased: | | | | | | | | | | |
Corporate equity securities ... | | | | | | | | | | |
Corporate debt securities ...... | | | | | | | | | | |
CMBS ........................................ | | | | | | | | | | |
Loans ........................................ | | | | | | | | | | |
Net derivatives (2) ................... | | | | | | | | | | |
Other secured financings ....... | | | | | | | | | | |
Long-term debt ........................ | | | | | | | | | | |
(1)Realized and unrealized gains/losses are primarily reported in Principal transactions revenues. Changes in instrument-specific credit risk related to structured notes
within Long-term debt are presented net of tax in our Consolidated Statements of Comprehensive Income.
(2)Net derivatives represent Financial instruments owned—Derivatives and Financial instruments sold, not yet purchased—Derivatives.
Analysis of Level 3 Assets and Liabilities for the Year Ended
November 30, 2025
Transfers of assets of $82.6 million from Level 2 to Level 3 of the
fair value hierarchy are primarily attributed to:
•Loans and other receivables of $28.4 million, CDOs and CLOs
of $20.1 million, corporate equity securities of $17.0 million
and other ABS of $15.4 million due to reduced pricing
transparency.
Transfers of assets of $178.3 million from Level 3 to Level 2 are
primarily attributed to:
•Loans and other receivables of $63.5 million, corporate equity
securities of $50.8 million, CDOs and CLOs of $45.8 million,
investments at fair value of $11.3 million and other ABS of $5.1
million due to greater pricing transparency.
Transfers of liabilities of $16.0 million from Level 2 to Level 3 of
the fair value hierarchy are primarily attributed to:
•Structured notes within long-term debt of $7.2 million, net
derivatives of $5.6 million and loans of $2.3 million due to
reduced pricing and market transparency.
Transfers of liabilities of $39.8 million from Level 3 to Level 2 of
the fair value hierarchy are primarily attributed to:
•Structured notes within long-term debt of $32.1 million and net
derivatives of $6.5 million due to greater pricing and market
transparency.
Net losses on Level 3 assets were $19.6 million and net losses
on Level 3 liabilities were $5.7 million for the year ended
November 30, 2025. Net losses on Level 3 assets were primarily
due to decreased market values in CDOs and CLOs, corporate
equity securities, other ABS and loans and other receivables,
partially offset by increases in the market values of investments
at fair value and corporate debt securities. Net losses on Level 3
liabilities were primarily due to increased market valuations of
certain structured notes within long-term debt and corporate debt
securities, partially offset by decreases in the market valuations
of loans, certain derivatives and other secured financings.
| | | | | | | | | | |
| | | | | | | | | For instruments still held at November 30, 2024, changes in unrealized gains/(losses) included in: |
| Balance at November 30, 2023 | Total gains/ losses (realized and unrealized) (1) | | | | | Net transfers into/ (out of) Level 3 | Balance at November 30, 2024 | | Other comprehensive income (1) |
| | | | | | | | | | |
Financial instruments owned: | | | | | | | | | | |
Corporate equity securities ....................... | | | | | | | | | | |
Corporate debt securities | | | | | | | | | | |
CDOs and CLOs ................. | | | | | | | | | | |
Sovereign obligations ....... | | | | | | | | | | |
RMBS .................................. | | | | | | | | | | |
CMBS .................................. | | | | | | | | | | |
Other ABS ........................... | | | | | | | | | | |
Loans and other receivables .................... | | | | | | | | | | |
Investments at fair value . | | | | | | | | | | |
| | | | | | | | | | |
Financial instruments sold, not yet purchased: | | | | | | | | | | |
Corporate equity securities ....................... | | | | | | | | | | |
Corporate debt securities | | | | | | | | | | |
CMBS .................................. | | | | | | | | | | |
Loans .................................. | | | | | | | | | | |
Net derivatives (2) ............. | | | | | | | | | | |
Other secured financings . | | | | | | | | | | |
Long-term debt .................. | | | | | | | | | | |
(1)Realized and unrealized gains/losses are primarily reported in Principal transactions revenues. Changes in instrument-specific credit risk related to structured notes
within Long-term debt are presented net of tax in our Consolidated Statements of Comprehensive Income.
(2)Net derivatives represent Financial instruments owned—Derivatives and Financial instruments sold, not yet purchased—Derivatives.
Analysis of Level 3 Assets and Liabilities for the Year Ended
November 30, 2024
Transfers of assets of $90.5 million from Level 2 to Level 3 of the
fair value hierarchy are primarily attributed to:
•Other ABS of $47.6 million, corporate equity securities of $22.7
million, loans and other receivables of $14.9 million, CDOs and
CLOs of $2.7 million and corporate debt securities of $2.0
million due to reduced pricing transparency.
Transfers of assets of $66.9 million from Level 3 to Level 2 are
primarily attributed to:
•Other ABS of $19.0 million, RMBS of $14.6 million, corporate
equity securities of $9.7 million, CDOs and CLOs of $8.2 million
and loans and other receivables of $8.1 million due to greater
pricing transparency.
Transfers of liabilities of $30.1 million from Level 2 to Level 3 of
the fair value hierarchy are primarily attributed to:
•Structured notes within long-term debt of $26.8 million and net
derivatives of $3.1 million due to reduced pricing and market
transparency.
Transfers of liabilities of $40.4 million from Level 3 to Level 2 of
the fair value hierarchy are primarily attributed to:
•Structured notes within long-term debt of $27.8 million and net
derivatives of $13.6 million due to greater pricing and market
transparency.
Net losses on Level 3 assets were $52.0 million and net losses
on Level 3 liabilities were $47.1 million for the year ended
November 30, 2024. Net losses on Level 3 assets were primarily
due to decreased market values in loans and other receivables,
other ABS, investments at fair value, CDOs and CLOs, corporate
equity securities and corporate debt securities. Net losses on
Level 3 liabilities were primarily due to increased market other
secured financings, partially offset by decreases in certain
derivatives.
| | | | | | | | | | |
| | | | | | | | | For instruments still held at November 30, 2023, changes in unrealized gains/(losses) included in: |
| Balance at November 30, 2022 | Total gains/ losses (realized and unrealized) (1) | | | | | Net transfers into/ (out of) Level 3 | Balance at November 30, 2023 | | Other comprehensive income (1) |
| | | | | | | | | | |
Financial instruments owned: | | | | | | | | | | |
Corporate equity securities ....................... | | | | | | | | | | |
Corporate debt securities | | | | | | | | | | |
CDOs and CLOs ................. | | | | | | | | | | |
RMBS .................................. | | | | | | | | | | |
CMBS .................................. | | | | | | | | | | |
Other ABS ........................... | | | | | | | | | | |
Loans and other receivables .................... | | | | | | | | | | |
Investments, at fair value . | | | | | | | | | | |
| | | | | | | | | | |
Financial instruments sold, not yet purchased: | | | | | | | | | | |
Corporate equity securities ....................... | | | | | | | | | | |
Corporate debt securities | | | | | | | | | | |
CMBS .................................. | | | | | | | | | | |
Loans .................................. | | | | | | | | | | |
Net derivatives (2) ............. | | | | | | | | | | |
Other secured financings . | | | | | | | | | | |
Long-term debt .................. | | | | | | | | | | |
(1)Realized and unrealized gains/losses are primarily reported in Principal transactions revenues. Changes in instrument-specific credit risk related to structured notes
within long-term debt are presented net of tax in our Consolidated Statements of Comprehensive Income.
(2)Net derivatives represent Financial instruments owned—Derivatives and Financial instruments sold, not yet purchased —Derivatives.
Analysis of Level 3 Assets and Liabilities for the Year Ended
November 30, 2023
Transfers of assets of $88.5 million from Level 2 to Level 3 of the
fair value hierarchy are primarily attributed to:
•Other ABS of $57.8 million, loans and other receivables of
$16.5 million, corporate debt securities of $8.9 million and
corporate equity securities of $5.3 million due to reduced price
transparency.
Transfers of assets of $78.2 million from Level 3 to Level 2 are
primarily attributed to:
•Loans and other receivables of $32.4 million, other ABS of
$24.3 million, CDOs and CLOs of $14.0 million and corporate
equity securities of $6.0 million due to greater pricing
transparency supporting classification into Level 2.
Transfers of liabilities of $60.8 million from Level 2 to Level 3 are
primarily attributed to:
•Net derivatives of $35.6 million and structured notes within
long-term debt of $25.2 million due to reduced pricing and
market transparency.
Transfers of liabilities of $62.0 million from Level 3 to Level 2 are
primarily attributed to:
•Net derivatives of $32.0 million and structured notes within
long-term debt of $29.8 million due to greater pricing
transparency.
Net gains on Level 3 assets were $38.5 million and net losses on
Level 3 liabilities were $62.9 million for the year ended November
30, 2023. Net gains on Level 3 assets were primarily due to
increased market values in investments at fair value, CDOs and
CLOs and loans and other receivables, partially offset by
decreases in corporate equity securities and other ABS. Net
losses on Level 3 liabilities were primarily due to increased
market valuations of certain structured notes within long-term
debt, partially offset by decreases in certain derivatives.
Significant Unobservable Inputs used in Level 3 Fair Value Measurements
The tables below present information on the valuation
techniques, significant unobservable inputs and their ranges for
our financial assets and liabilities, subject to threshold levels
related to the market value of the positions held, measured at fair
value on a recurring basis with a significant Level 3 balance. The
range of unobservable inputs could differ significantly across
different firms given the range of products across different firms
in the financial services sector. The inputs are not representative
of the inputs that could have been used in the valuation of any
one financial instrument (i.e., the input used for valuing one
financial instrument within a particular class of financial
instruments may not be appropriate for valuing other financial
instruments within that given class). Additionally, the ranges of
inputs presented below should not be construed to represent
uncertainty regarding the fair values of our financial instruments;
rather, the range of inputs is reflective of the differences in the
underlying characteristics of the financial instruments in each
category.
For certain categories, we have provided a weighted average of
the inputs allocated based on the fair values of the financial
instruments comprising the category. We do not believe that the
range or weighted average of the inputs is indicative of the
reasonableness of uncertainty of our Level 3 fair values. The
range and weighted average are driven by the individual financial
instruments within each category and their relative distribution in
the population. The disclosed inputs when compared to the
inputs as disclosed in other periods should not be expected to
necessarily be indicative of changes in our estimates of
unobservable inputs for a particular financial instrument as the
population of financial instruments comprising the category will
vary from period to period based on purchases and sales of
financial instruments during the period as well as transfers into
and out of Level 3 each period.
| | | | | | | |
|
Financial Instruments Owned | | | Significant Unobservable Input(s) | | |
Corporate equity securities ..................... | | | | | | | |
Non-exchange-traded securities | | | | | | |
| | | | | | |
Corporate debt securities ........................ | | | | | | | |
| | | | | | | |
| | | Estimated recovery percentage | | |
CDOs and CLOs .......................................... | | | | | |
| | | | | |
| | | | | |
| | | | | |
| | | | | | | |
RMBS ........................................................... | | | | | |
| | | | | |
| | | | | |
| | | | | |
Other ABS ................................................... | | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | Estimated recovery percentage | | |
Loans and other receivables ................... | | | | | | | |
| | | Estimated recovery percentage | | | | |
Derivatives .................................................. | | | | | | | |
| | | | | | | |
| | | | | |
Investments at fair value .......................... | | | | | | | |
Private equity securities | | | | | | | |
| | | | | |
| | | | | |
Financial Instruments Sold, Not Yet Purchased: | | | | | | |
Corporate debt securities ........................ | | | Estimated recovery percentage | | |
Loans .......................................................... | | | | | | | |
| | | Estimated recovery percentage | | |
Derivatives .................................................. | | | | | | | |
| | | | | | | |
| | | | | | | |
Other secured financings ......................... | | | Estimated recovery percentage | | | | |
| | | | | | | |
Long-term debt .......................................... | | | | | | | |
| | | | | | | |
| | | | | | | |
|
Financial Instruments Owned | | | Significant Unobservable Input(s) | | |
Corporate equity securities ..................... | | | | | | | |
Non-exchange-traded securities | | | | | | |
Corporate debt securities ........................ | | | | | | | |
CDOs and CLOs .......................................... | | | | | |
| | | | | |
| | | | | |
| | | | | | | |
| | | | | | | |
RMBS ........................................................... | | | | | |
| | | | | |
| | | | | |
Other ABS ................................................... | | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | Estimated recovery percentage | | |
Loans and other receivables ................... | | | | | | | |
| | | Estimated recovery percentage | | | | |
Derivatives .................................................. | | | | | | | |
| | | | | |
Investments at fair value .......................... | | | | | | | |
Private equity securities | | | | | | | |
| | | | | |
| | | | | |
Financial Instruments Sold, Not Yet Purchased: | | | | | | |
Loans .......................................................... | | | | | | | |
| | | Estimated recovery percentage | | | | |
Derivatives .................................................. | | | | | | | |
| | | | | | | |
| | | | | | | |
Other secured financings ......................... | | | Estimated recovery percentage | | | | |
| | | | | |
Long-term debt .......................................... | | | | | | | |
| | | | | | | |
The fair values of certain Level 3 assets and liabilities that were
determined based on third-party pricing information, unadjusted
past transaction prices or a percentage of the reported enterprise
fair value are excluded from the above tables. At November 30,
2025 and 2024, asset exclusions consisted of $28.2 million and
$23.9 million, respectively, primarily composed of CDOs and
CLOs, Investments at fair value, certain derivatives, other ABS
and CMBS. At November 30, 2025 and 2024, liability exclusions
consisted of $0.2 million and $2.7 million, respectively, primarily
composed of CMBS, certain derivatives, corporate equity
securities and corporate debt securities.
Uncertainty of Fair Value Measurement from Use of Significant
Unobservable Inputs
For recurring fair value measurements categorized within Level 3
of the fair value hierarchy, the uncertainty of the fair value
measurement due to the use of significant unobservable inputs
and interrelationships between those unobservable inputs (if any)
are described below:
•Non-exchange-traded securities, corporate debt securities,
CDOs and CLOs, loans and other receivables, RMBS, other ABS,
private equity securities, certain derivatives, other secured
financings and structured notes using a market approach
valuation technique. A significant increase (decrease) in the
price of the private equity securities, nonexchange-traded
securities, corporate debt securities, CDOs and CLOs, RMBS,
other ABS, loans and other receivables, other secured
financings and structured notes would result in a significantly
higher (lower) fair value measurement. A significant increase
(decrease) in the revenue or revenue multiple related to private
equity securities would result in a significantly higher (lower)
fair value measurement. A significant increase (decrease) in
the discount rate/security yield related to private equity
securities would result in a significantly lower (higher) fair
value measurement. Depending on whether we are a receiver
or (payer) of basis points upfront, a significant increase in
basis points would result in a significant increase (decrease) in
the fair value measurement of options.
•Corporate debt securities, loans and other receivables, other
ABS and other secured financings using a scenario analysis
valuation technique. A significant increase (decrease) in the
possible recovery rates underlying the financial instrument
would result in a significantly higher (lower) fair value
measurement for the financial instrument.
•CDOs and CLOs, corporate debt securities, RMBS and other
ABS using a discounted cash flows valuation technique. A
significant increase (decrease) in isolation in the constant
default rate, loss severity or cumulative loss rate would result
in a significantly lower (higher) fair value measurement. The
impact of changes in the constant prepayment rate and
duration would have differing impacts depending on the capital
structure and type of security. A significant increase
(decrease) in the discount rate/security yield would result in a
significantly lower (higher) fair value measurement.
•Corporate equity securities and derivative equity options using
volatility benchmarking. A significant increase (decrease) in
volatility would result in a significantly higher (lower) fair value
measurement.
Fair Value Option ElectionWe have elected the fair value option for all loans and loan
commitments made by our investment banking and capital
markets businesses. These loans and loan commitments include
loans entered into by our investment banking division in
connection with client bridge financing and loan syndications,
loans purchased by our leveraged credit trading desk as part of
its bank loan trading activities and mortgage and consumer loan
commitments, purchases and fundings in connection with
mortgage-backed and other asset-backed securitization
activities. Loans and loan commitments originated or purchased
by our leveraged credit and mortgage-backed businesses are
managed on a fair value basis. Loans are included in Financial
instruments owned and loan commitments are included in
Financial instruments owned and Financial instruments sold, not
yet purchased. The fair value option election is not applied to
loans made to affiliate entities as such loans are entered into as
part of ongoing, strategic business ventures. Loans to affiliate
entities are included in Investments in and loans to related
parties and are accounted for on an amortized cost basis. We
have also elected the fair value option for certain of our
structured notes which are managed by our investment banking
and capital markets businesses and are included in Long-term
debt. We have elected the fair value option for certain financial
instruments held by subsidiaries as the investments are risk
managed by us on a fair value basis. The fair value option has
been elected for certain other secured financings that arise in
connection with our securitization activities and other structured
financings. Other secured financings, Receivables – Brokers,
dealers and clearing organizations, Receivables – Customers,
Receivables – Fees, interest and other, Payables – Brokers,
dealers and clearing organizations and Payables – Customers,
are accounted for at cost plus accrued interest rather than at fair
value; however, the recorded amounts approximate fair value due
to their liquid or short-term nature.
Gains (losses) due to changes in fair value related to instrument-
specific credit risk on loans, other receivables and debt
instruments and gains (losses) due to other changes in fair value
on Long-term debt measured at fair value under the fair value
option:
| | | |
| |
| | | |
Financial instruments owned: | | | |
Loans and other receivables .......... | | | |
Other secured financings: | | | |
Other changes in fair value (2) ...... | | | |
| | | |
Changes in instrument-specific credit risk (1) .................................... | | | |
Other changes in fair value (2) ...... | | | |
(1)Changes in fair value of structured notes related to instrument-specific credit
risk are presented net of tax in our Consolidated Statements of
Comprehensive Income.
(2)Other changes in fair value are included in Principal transactions revenues.
Difference between contractual principal and fair value (1):
| | |
| |
| | |
Financial instruments owned: | | |
Loans and other receivables (2) ................................ | | |
Loans and other receivables on nonaccrual status and/or 90 days or greater past due (2) ..... | | |
Loans and other receivables 90 days or greater past due (2) .............................................. | | |
Long-term debt ............................................................. | | |
Other secured financings ............................................ | | |
(1)Amounts indicate contractual principal greater than or (less than) fair value.
(2)Interest income is recognized separately from other changes in fair value and
is included in Interest revenues.
Fair value of loans and other receivables on nonaccrual status:
| | |
| |
| | |
Financial instruments owned: | | |
Loans and other receivables on nonaccrual status and/or 90 days or greater past due ........................... | | |
Loans and other receivables 90 days or greater past due ..................................................................... | | |
Assets Measured at Fair Value on a Non-recurring Basis Certain assets were measured at fair value on a non-recurring
basis and are not included in the tables above. There were no
non-recurring fair value adjustments for the year ended
November 30, 2025. Assets measured at fair value on a non-
recurring basis for which we recognized a non-recurring fair value
adjustment for the periods presented:
| | |
November 30, 2024 (in thousands) | | |
Premises and equipment (1) ......................................... | | |
Exchange ownership interests and registrations (2) . | | |
Other assets (3) .............................................................. | | |
| | |
November 30, 2023 (in thousands) | | |
Exchange ownership interests and registrations (2) . | | |
Investments in and loans to related parties (4) ......... | | |
Other assets (5) .............................................................. | | |
(1)Premises and equipment losses represent impairments of leasehold
improvements, furniture, fixtures, computer and communications equipment
and capitalized software and were recognized in Technology and
communications and Occupancy and equipment rental in our Consolidated
Statements of Earnings.
(2)These impairment losses, which represent ownership interests in market
exchanges on which trading business is conducted, and registrations, were
recognized in Other expenses and the assets were in the Investment Banking
and Capital Markets reportable business segment. The fair value is based on
observed quoted sales prices for each individual membership.
(3)Our shares in Monashee, an equity method investment, were converted to a
newly created class of nonmarketable preferred shares. Our equity method
investment was remeasured in connection with its nonmonetary exchange
into the preferred shares, which are accounted for at cost pursuant to the
measurement alternative subsequent to the nonmonetary exchange. The gain
was recognized in Other revenues and the asset was in the Asset
Management reportable business segment.
(4)These impairment losses, which are related to an equity method investments,
were recognized in Other revenues and the asset was in the Asset
Management reportable business segment. Fair value was based on our best
estimate of what could be recognized in a sale transaction for the investment.
(5)These impairment losses, which are related to real estate held for
development, were recognized in Other revenues and are held in the Asset
Management reportable business segment. Fair value was based on
estimated future cash flows using discounts rates ranging from 10.0% to
14.0%.
Financial Instruments Not Measured at Fair ValueCertain of our financial instruments are not carried at fair value
but are recorded at amounts that approximate fair value due to
their liquid or short-term nature and generally negligible credit
risk. These financial assets include Cash and cash equivalents
and Cash and securities segregated and on deposit for regulatory
purposes or deposited with clearing and depository organizations
and would generally be presented within Level 1 of the fair value
hierarchy.
We have equity securities without readily determinable fair
values, which we account for at cost, minus impairment, which
are presented within Other assets and were $21.9 million at both
November 30, 2025 and 2024. There were no net gains or
(losses) recognized on these investments during the years ended
November 30, 2025 and 2024. Net losses of $122.2 million were
recognized on these investments during the year ended
November 30, 2023. Impairments and downward adjustments on
these investments during the year ended November 30, 2023
were $80.3 million. There were no impairments and downward
adjustments on these investments during the years ended
November 30, 2025 and 2024. These investments would
generally be presented within Level 3 of the fair value hierarchy.